Payment overview · 2025
General Payments
$84.44
3 reported records · 3 companies
Healthcare provider profile · identity verified
Christopher P Lafollette, MD
Allopathic & Osteopathic Physicians|Family Medicine · BLOOMINGTON, IN · NPI 1528173341
Verified facts
What the public records show
CMS Open Payments records show Christopher P Lafollette, MD received $84.44 in general payments during 2025 across 3 reported records.
Abbott Laboratories accounted for 59.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Abbott Laboratories | Unresolved — no canonical attribution shown | $49.95 | 59.1% | 1 | 2025 |
| Edwards Lifesciences Corporation | Unresolved — no canonical attribution shown | $18.20 | 21.6% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $16.29 | 19.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Long term medical supply or device loan | $49.95 | 1 |
| Food and Beverage | $34.49 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FREESTYLE INSULINX Normalized: freestyle insulinx |
Device | Abbott Laboratories | $49.95 | 1 | 2025 |
Source payment records
|
|||||
| SAPIEN 3 Ultra RESILIA Normalized: sapien 3 ultra resilia |
Device | Edwards Lifesciences Corporation | $18.20 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $16.29 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 684 | 166 |
| Amlodipine Besylate | Amlodipine Besylate | 653 | 161 |
| Atorvastatin Calcium | Atorvastatin Calcium | 571 | 156 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 520 | 139 |
| Simvastatin | Simvastatin | 380 | 97 |
| Lisinopril | Lisinopril | 363 | 94 |
| Omeprazole | Omeprazole | 339 | 95 |
| Losartan Potassium | Losartan Potassium | 316 | 78 |
| Tamsulosin Hcl | Tamsulosin Hcl | 288 | 83 |
| Pantoprazole Sodium | Pantoprazole Sodium | 274 | 70 |
| Hydrochlorothiazide | Hydrochlorothiazide | 238 | 70 |
| Alprazolam | Alprazolam | 213 | 52 |
| Sertraline Hcl | Sertraline Hcl | 212 | 56 |
| Metformin Hcl Er | Metformin Hcl | 210 | 62 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 182 | 34 |
| Tramadol Hcl | Tramadol Hcl | 172 | 34 |
| Gabapentin | Gabapentin | 164 | 51 |
| Montelukast Sodium | Montelukast Sodium | 162 | 44 |
| Meloxicam | Meloxicam | 160 | 45 |
| Pravastatin Sodium | Pravastatin Sodium | 150 | 37 |
| Trazodone Hcl | Trazodone Hcl | 147 | 48 |
| Jardiance | Empagliflozin | 143 | 34 |
| Mounjaro | Tirzepatide | 139 | 20 |
| Potassium Chloride | Potassium Chloride | 130 | 34 |
| Valsartan | Valsartan | 130 | 34 |
| Metformin Hcl | Metformin Hcl | 127 | 33 |
| Atenolol | Atenolol | 122 | 36 |
| Metoprolol Succinate | Metoprolol Succinate | 116 | 33 |
| Escitalopram Oxalate | Escitalopram Oxalate | 115 | 33 |
| Carvedilol | Carvedilol | 109 | 24 |
| Furosemide | Furosemide | 98 | 30 |
| Glipizide Er | Glipizide | 98 | 28 |
| Allopurinol | Allopurinol | 96 | 27 |
| Clonazepam | Clonazepam | 95 | 16 |
| Warfarin Sodium | Warfarin Sodium | 90 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 89 | 22 |
| Duloxetine Hcl | Duloxetine Hcl | 86 | 24 |
| Finasteride | Finasteride | 81 | 20 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 81 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 78 | 28 |
| Lorazepam | Lorazepam | 74 | 14 |
| Clopidogrel | Clopidogrel Bisulfate | 73 | 19 |
| Spironolactone | Spironolactone | 72 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 68 | 19 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 66 | 31 |
| Metoprolol Tartrate | Metoprolol Tartrate | 66 | 20 |
| Synthroid | Levothyroxine Sodium | 66 | 19 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 61 | 16 |
| Ozempic | Semaglutide | 58 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 56 | 16 |
| Celecoxib | Celecoxib | 53 | 18 |
| Famotidine | Famotidine | 53 | 13 |
| Irbesartan | Irbesartan | 51 | 13 |
| Prednisone | Prednisone | 51 | 37 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 49 | 12 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 49 | 11 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 46 | suppressed |
| Glimepiride | Glimepiride | 46 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 46 | 17 |
| Eliquis | Apixaban | 45 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 44 | 13 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 44 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 42 | 41 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 41 | 12 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 40 | 31 |
| Lansoprazole | Lansoprazole | 38 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 38 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 37 | 17 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 37 | suppressed |
| Memantine Hcl | Memantine Hcl | 37 | 13 |
| Trulicity | Dulaglutide | 37 | suppressed |
| Bupropion Xl | Bupropion Hcl | 36 | 12 |
| Januvia | Sitagliptin Phosphate | 36 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 35 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 35 | 31 |
| Lamotrigine | Lamotrigine | 35 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 34 | 11 |
| Solifenacin Succinate | Solifenacin Succinate | 34 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 34 | 23 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 33 | 28 |
| Sumatriptan Succinate | Sumatriptan Succinate | 33 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 32 | suppressed |
| Ketoconazole | Ketoconazole | 32 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 32 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 30 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 29 | suppressed |
| Ezetimibe | Ezetimibe | 29 | suppressed |
| Temazepam | Temazepam | 29 | suppressed |
| Ondansetron Odt | Ondansetron | 28 | suppressed |
| Verapamil Er | Verapamil Hcl | 28 | suppressed |
| Adacel Tdap | Diph,pertuss(Acell),tet Vac/Pf | 27 | 27 |
| Benazepril Hcl | Benazepril Hcl | 27 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 27 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 26 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 26 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 26 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 25 | suppressed |
| Acyclovir | Acyclovir | 24 | 12 |
| Mirtazapine | Mirtazapine | 24 | suppressed |
| Cephalexin | Cephalexin | 23 | 20 |
| Amitriptyline Hcl | Amitriptyline Hcl | 22 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 22 | suppressed |
| Methadone Hcl | Methadone Hcl | 21 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 20 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 20 | suppressed |
| Tradjenta | Linagliptin | 19 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 19 | suppressed |
| Creon | Lipase/Protease/Amylase | 18 | suppressed |
| Diazepam | Diazepam | 18 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 18 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 18 | 18 |
| Amoxicillin | Amoxicillin | 17 | 16 |
| Farxiga | Dapagliflozin Propanediol | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | 15 |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | 11 |
| Pregabalin | Pregabalin | 16 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 15 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Clotrimazole | Clotrimazole | 13 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 13 | suppressed |
| Jentadueto Xr | Linagliptin/Metformin Hcl | 13 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 13 | suppressed |
| Nabumetone | Nabumetone | 13 | suppressed |
| Naproxen | Naproxen | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 13 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 12 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 12 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 12 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 12 | suppressed |
| Lactulose | Lactulose | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 12 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 12 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 12 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 11 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 11 | suppressed |
| Azithromycin | Azithromycin | 11 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Cilostazol | Cilostazol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $84.44 · 3 records | Abbott Laboratories | FREESTYLE INSULINX, SAPIEN 3 Ultra RESILIA, The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error